A laboratory study found that Leuconostoc mesenteroides H40, a probiotic bacteria, reduced inflammatory chemicals by 50 to 70 percent in human intestinal cells and protected the proteins that seal the gut barrier. According to Gram Research analysis, the bacteria also increased serotonin-related gene expression, suggesting potential benefits for both digestive and mood health. However, these results come from laboratory cells, not humans, so additional research is needed before this probiotic can be recommended as a treatment.
Researchers tested a specific probiotic bacteria called Leuconostoc mesenteroides H40 in laboratory gut cells to see if it could reduce inflammation and strengthen the intestinal barrier. According to Gram Research analysis, this probiotic showed promising results by reducing inflammatory chemicals, protecting the proteins that hold gut cells together, and potentially supporting mood-related pathways in the gut. The bacteria appears to work through multiple mechanisms, including producing protective compounds and supporting healthy gut chemistry. While these lab results are encouraging, human studies are needed to confirm whether taking this probiotic as a supplement would provide similar benefits.
Key Statistics
A 2026 laboratory study found that Leuconostoc mesenteroides H40 reduced inflammatory chemicals including IL-6, IL-8, and TNF-alpha by 50 to 70 percent in human intestinal cells exposed to bacterial triggers.
Research published in the Journal of Microbiology and Biotechnology showed that the probiotic strain preserved or enhanced intestinal barrier proteins including claudin-1, occludin, and MUC2, which form the seals between gut cells.
The bacterial strain harbors genes for producing exopolysaccharides, antioxidant compounds, and B-vitamins, suggesting it works through multiple protective mechanisms in the intestinal system.
The Quick Take
- What they studied: Whether a specific probiotic bacteria could reduce inflammation and strengthen the protective barrier of intestinal cells
- Who participated: Laboratory-grown human intestinal cells (HT-29 cells) that were treated with inflammatory triggers to mimic gut damage
- Key finding: The probiotic bacteria reduced inflammatory chemicals by 50 to 70 percent and preserved the proteins that seal gaps between gut cells, preventing harmful substances from leaking through
- What it means for you: This probiotic shows potential as a supplement to support gut health and reduce inflammation, but human studies are needed before recommending it as a treatment. People with inflammatory bowel conditions may eventually benefit, but more research is required.
The Research Details
Scientists grew human intestinal cells in laboratory dishes and exposed them to lipopolysaccharide (LPS), a bacterial compound that triggers inflammation similar to what happens during gut infections or inflammation. They then treated these cells with Leuconostoc mesenteroides H40, a type of probiotic bacteria, to see if it could reduce the inflammatory response. The researchers measured multiple markers of inflammation and gut barrier function, including inflammatory chemicals like IL-6 and IL-8, as well as proteins that seal the gaps between intestinal cells. They also analyzed the bacteria’s genetic code to understand what compounds it produces that might explain its protective effects.
This research approach is important because it allows scientists to understand the specific mechanisms by which a probiotic works before testing it in humans. By studying individual cells in controlled conditions, researchers can identify exactly which inflammatory pathways the bacteria blocks and which protective proteins it preserves. This information helps predict whether the probiotic might actually help people with gut inflammation or intestinal barrier problems. The genetic analysis also reveals what compounds the bacteria produces, which helps explain why it works.
This is a laboratory study using cultured cells, which is a standard first step in probiotic research but has important limitations. The study was published in a peer-reviewed journal, suggesting it met scientific standards. However, results in laboratory cells do not automatically translate to benefits in living people. The study did not involve human participants, so we cannot yet know if taking this probiotic as a supplement would produce similar protective effects. Additional studies in animals and eventually humans would be needed to confirm these findings.
What the Results Show
The probiotic bacteria significantly reduced inflammatory chemicals in the intestinal cells. Specifically, it lowered nitric oxide production, which is a marker of cellular stress, and suppressed the production of multiple inflammatory proteins including IL-1 beta, IL-6, IL-8, TNF-alpha, and COX-2. These are the same inflammatory chemicals that become elevated in conditions like inflammatory bowel disease and food sensitivities. The bacteria also prevented the loss of proteins that form tight seals between intestinal cells, including claudin-1, occludin, and MUC2. These sealing proteins are critical because when they break down, harmful bacteria and toxins can leak through the intestinal wall into the bloodstream, a condition sometimes called leaky gut. The protective effect was strong enough that some of these barrier proteins were actually enhanced rather than just preserved.
The research revealed an unexpected finding related to mood and gut health. The probiotic increased expression of genes involved in serotonin production and transport in the intestinal cells. Serotonin is a chemical messenger that affects mood, and about 90 percent of the body’s serotonin is produced in the gut. This suggests the probiotic may influence the gut-brain axis, the communication system between the digestive system and the brain. The genetic analysis showed the bacteria produces compounds that protect against oxidative stress, support B-vitamin production, and help break down tryptophan, an amino acid that the body converts to serotonin. These features suggest the probiotic works through multiple pathways simultaneously.
This research builds on existing knowledge that certain probiotic bacteria can reduce inflammation and support gut barrier function. Previous studies have shown that other Leuconostoc species have anti-inflammatory properties, but this specific strain (H40) appears to have particularly strong effects on barrier proteins and serotonin-related pathways. The finding that a probiotic can influence serotonin production aligns with growing research on the gut-brain connection, though this is still an emerging area. The multi-mechanism approach observed in this study, where the bacteria works through inflammation reduction, barrier protection, and neurotransmitter support, is more comprehensive than many previously studied probiotics.
This study has several important limitations. First, it was conducted entirely in laboratory cells, not in living organisms or humans. Cells in a dish do not experience the complex environment of the human digestive system, including stomach acid, bile, food interactions, and the presence of trillions of other bacteria. Second, the study did not specify how many experiments were conducted or provide detailed statistical analysis, making it difficult to assess the reliability of the findings. Third, the inflammatory trigger used (LPS) is a specific type of bacterial component that may not represent all types of gut inflammation. Fourth, we do not know if the probiotic would survive the journey through the stomach and reach the intestines in sufficient quantities to produce these effects in humans. Finally, this is a single study from one research group, so the findings need to be confirmed by independent researchers before drawing firm conclusions.
The Bottom Line
Based on this laboratory research, Leuconostoc mesenteroides H40 shows promise as a potential probiotic supplement for supporting gut health and reducing inflammation. However, confidence in this recommendation is currently low because human studies have not yet been conducted. People interested in supporting gut health should continue following established recommendations: eat a fiber-rich diet with plenty of vegetables and whole grains, stay hydrated, manage stress, and consider established probiotic strains that have human research supporting them. If you have inflammatory bowel disease or chronic digestive issues, consult your doctor before trying new supplements, as some probiotics may not be appropriate for certain conditions.
This research is most relevant to people with inflammatory bowel conditions, chronic gut inflammation, or intestinal barrier problems. It may also interest people concerned about gut-brain health and mood support. However, until human studies are completed, this probiotic should not be considered a treatment for any condition. People with compromised immune systems, severe illness, or those taking immunosuppressive medications should consult their doctor before trying new probiotics. Healthy individuals without digestive issues may not see noticeable benefits from this specific strain.
If this probiotic eventually becomes available as a supplement and proves effective in human studies, benefits would likely develop gradually over weeks to months rather than days. Gut barrier function and inflammation markers typically require 4 to 12 weeks of consistent probiotic use to show measurable changes. Any mood or digestive benefits would probably follow a similar timeline. It is important to have realistic expectations and understand that probiotics work best as part of a comprehensive approach to gut health, not as a standalone treatment.
Frequently Asked Questions
Can this probiotic help with inflammatory bowel disease?
Laboratory results suggest Leuconostoc mesenteroides H40 may reduce inflammation and protect the gut barrier, which are key problems in inflammatory bowel disease. However, human studies have not been conducted yet, so we cannot confirm effectiveness in people. Consult your doctor before trying new probiotics if you have IBD.
Does this probiotic improve mood and mental health?
The bacteria increased serotonin-related genes in intestinal cells, suggesting a potential gut-brain connection. However, this was only observed in laboratory cells, not in humans. Much more research is needed to determine whether taking this probiotic would actually improve mood or mental health.
When will this probiotic be available as a supplement?
This probiotic strain is not yet commercially available. Before it can be sold as a supplement, companies would need to conduct human studies, obtain regulatory approval, and develop manufacturing processes. This typically takes several years of additional research.
How does this probiotic compare to other probiotics I can buy now?
This strain has not been tested in humans, while many commercial probiotics have some human research supporting them. Established strains like Lactobacillus and Bifidobacterium have more evidence for digestive health benefits. This new strain shows promise but requires more research before comparison.
What does leaky gut mean and how does this probiotic help?
Leaky gut occurs when proteins sealing intestinal cells break down, allowing harmful substances to enter the bloodstream. This probiotic protected these sealing proteins in laboratory cells, potentially preventing leaky gut. However, human studies are needed to confirm this benefit actually occurs in people.
Want to Apply This Research?
- If this probiotic becomes available, track daily digestive symptoms using a simple 1-10 scale for bloating, gas, and discomfort. Also note energy levels and mood each day. Record consistency of supplement use. After 8 to 12 weeks, compare your baseline measurements to current status to assess whether the probiotic is helping.
- Start taking a daily probiotic supplement containing Leuconostoc mesenteroides H40 (once it becomes commercially available) at the same time each day, ideally with a meal. Pair this with increased fiber intake from vegetables and whole grains, which feeds beneficial bacteria. Track your adherence in the app to maintain consistency, as probiotics require regular use to be effective.
- Create a long-term tracking system that monitors digestive health markers weekly, including bloating, regularity, energy levels, and mood. Set monthly check-ins to review trends and determine if the probiotic is providing noticeable benefits. If no improvement appears after 12 weeks of consistent use, consider discussing alternative approaches with your healthcare provider.
This article summarizes laboratory research on a probiotic strain that has not yet been tested in humans. The findings are preliminary and should not be interpreted as medical advice or a recommendation to treat any condition. Leuconostoc mesenteroides H40 is not currently available as a commercial supplement. If you have inflammatory bowel disease, digestive disorders, or a compromised immune system, consult your healthcare provider before taking any new probiotic supplements. This research represents early-stage science and much additional work is needed before clinical applications can be considered.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.